Mass General Brigham, Inc
- SEC CIK
- 0001678378
- Latest filing
- Aug 7, 2026
Holdings in Q1 2026
Holdings as of Mar 31, 2026, filed May 5, 2026. Long positions only; changes compare share counts with Q4 2025.
- Positions
- 6
- −1 vs. Q4 2025
- Portfolio value
- $468.9M
- −$340.9M (−42.1%) vs. Q4 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| iShares Tr464288257 | MSCI ACWI ETF | 2,153,477 | $292.7M | 62.4% | −2,460,478−53.3% | Reduced | – |
| KRMNKarman Holdings Inc. | COMMON STOCK | 1,562,054 | $125.0M | 26.7% | 00.0% | Unchanged | History |
| RVMDRevolution Medicines, Inc. | COM | 344,091 | $33.5M | 7.1% | 00.0% | Unchanged | History |
| TNGXTango Therapeutics, Inc. | COM | 354,192 | $7.41M | 1.6% | 00.0% | Unchanged | History |
| MAZEMaze Therapeutics, Inc. | COM | 239,994 | $7.16M | 1.5% | 00.0% | Unchanged | History |
| MDLNMedline Inc. | COM CL A | 70,357 | $3.13M | 0.7% | +44,063+167.6% | Added | History |
Sold out since Q4 2025 (1)
Positions held at the end of Q4 2025 that are gone from this filing.